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Background: A multidrug-resistant (MDR) RR2 gene cluster was identified by whole-genome 
sequencing in several highly virulent (ST-17) Group B streptococcus (GBS) isolates, which 
caused neonatal invasive infections in southern China in 2016. Tracing the transmission and 
distribution of MDR isolates in this area is important for the effective management of future 
infections. The aim of this study was to obtain longitudinal data of MDR isolates to monitor 
epidemiological trends of general common isolates in southern China, and provide evidence 
for future characterization of antimicrobial resistance mechanisms.
Methods: Clinical information and antimicrobial susceptibility of GBS isolates were acquired 
from electronic information management system databases of the hospital under study between 
January 2011 and December 2017. To confirm the presence of intact RR2, the tetO, ant6, lnuB, 
and ant9 genes located upstream, midstream, and downstream of RR2 were detected by PCR 
and DNA sequencing.
Results: A total of 149 cases of neonatal invasive GBS infection were identified during the 
period 2011–2017. Among them, 119 cases (79.9%) were caused by MDR isolates, with a 
general increasing trend over the past 7 years. Further characterization of 11 isolates showed 
that six isolates causing late-onset disease (LOD) carry the tetO, ant6, and lnuB genes, which 
are located on RR2. Moreover, lnuB and ant9 consistently co-occurred in GBS isolates, which 
suggests their close proximity to one another in the RR2 gene cluster.
Conclusion: The MDR GBS is responsible for a large number of neonatal invasive infections 
and occurs with increasing frequency over time. Particularly, the MDR GBS isolates that cause 
LOD are more likely to carry the RR2 gene cluster, compared with those that cause early-onset 
disease. The rise in number of MDR GBS isolates emphasizes the pressing need for continuous 
surveillance to monitor their antibiotic susceptibility and epidemiology.
Keywords: invasive infection, gene cluster, neonates, multidrug-resistance
Introduction
Group B streptococcus (GBS or Streptococcus agalactiae) is a leading cause of 
neonatal morbidity and mortality. It is commonly found in the genital and gastroin-
testinal tracts of women. Approximately 10%–30% of pregnant women are colonized 
with GBS worldwide,1 and neonates can be affected by vertical transmission of the 
bacterium through contaminated amniotic or vaginal secretions of a colonized mother 
before or during delivery.2–4 An overall incidence of 0.55 per 1,000 live births in the 
urban areas of southern China was reported in our previous study.5 Following neonatal 
exposure to GBS during delivery, the bacteria can quickly spread into the bloodstream 
with rapid onset of illnesses diagnosed in hospitals, such as pneumonia, sepsis, or 
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meningitis.6–8 The overall fatality ratio in such cases is 9.6% 
(95% CI: 7.5–11.8).9 Among the infected infants who survive 
meningitis, some are affected by permanent neurological 
sequelae due to the absence of specific clinical symptoms 
for a proper diagnosis, and therefore, receive delayed treat-
ment.10–14 Overall, GBS infection affects both the neonate 
and the public health system.15,16
Neonatal GBS infections are of two types: early-onset dis-
ease (EOD) and late-onset disease (LOD). The EOD occurs 
during the first week of life (age 0–6 days) and accounts for 
30% of all GBS disease in neonates.1 The LOD occurs in 
newborns and infants aged 7–89 days. The EOD presents with 
sepsis (80%–85%), meningitis (7%), or pneumonia (10%), 
whereas the LOD primarily presents with bacteremia (65%), 
meningitis (25%–30%), or other signs (9%).17 The recom-
mended universal screening of pregnant women for GBS 
carriage and the use of intrapartum antibiotic prophylaxis 
during delivery have significantly reduced the incidence of 
EOD, but not the incidence of LOD.7
Two groups of antibiotics, penicillins and aminopenicil-
lins, are recommended as first-line therapy against GBS 
infections; macrolides (erythromycin) and lincosamide 
(clindamycin) represent the second-line antibiotics that are 
usually prescribed for those with an allergy to beta-lactams.2,4 
Within recent years, the emerging antimicrobial resistance 
in clinical settings has become a threat to public health 
worldwide.3,5,18 The GBS with reduced penicillin susceptibil-
ity (PRGBS) in isolated strains from clinical settings rose 
from 2.3% to 14.7% between 2005 and 2013 in Japan.18 In 
the USA, clindamycin-resistant GBS and erythromycin-
resistant isolates increased from 10.5% to 15.0% and 15.8% 
to 32.8%, respectively.19 China is even more severely affected, 
as clindamycin and erythromycin resistance occurs at very 
high levels of 87.5% and 92.5%, respectively.20 In 2014, the 
situation worsened owing to the appearance of a vancomycin-
resistant strain; vancomycin is the last-line drug for treatment 
against GBS infections.21
A multidrug-resistant (MDR) isolate refers to a strain 
that is resistant to three or more types of antimicrobial drugs 
simultaneously. Several infections caused by MDR GBS have 
been reported.18,22 Moreover, an MDR gene cluster, which 
is harbored in integrative and conjugative elements (ICEs), 
named RR2, has been identified in several MDR clinical 
isolates from southern China.23 The RR2 gene cluster car-
ries several antibiotic resistance genes, including tetO for 
tetracyclines, lnuB for lincosamides, ant6, ant9, and aphA 
for aminoglycosides, and ermB for macrolides. Despite this 
marked increase in antibiotic resistance, the isolation rate of 
MDR GBS has not been widely investigated in the region of 
southern China, and the roles of RR2 in MDR GBS infection 
remain unclear.
In this study, a longitudinal survey of population-based 
surveillance of neonatal invasive GBS infection in southern 
China from 2011 to 2017 was undertaken to assess trends in 
the epidemiology of MDR isolates. Furthermore, 11 isolates 
were selected to probe for tetO, ant6, lnuB, and ant9 genes 
located upstream, midstream, and downstream of the RR2 
gene cluster to investigate whether partial or intact RR2 is 
present in these isolates. This study may shed light on the 
trends of MDR GBS infection in southern China and may 
provide new directions for the study of the mechanisms of 
antimicrobial resistance in GBS.
Materials and methods
Bacterial strains
Routine laboratory reports of neonatal invasive GBS dis-
ease submitted by microbiology laboratories of Guangzhou 
Women and Children’s Medical Center were reviewed for 
the period 1 January 2011 to 31 December 2017. Laboratory 
surveillance is subject to internal quality control and external 
quality assessment. An invasive infection was defined as 
yielding positive GBS cultured from blood or non-sterile 
sites and clinical symptoms.24 Records were considered as 
the same episode if specimens were taken within 7 days and 
showed the same biological response; they were thus merged 
accordingly to form a single record. A portion of the cases 
and isolates from 2011 to 2014 described here have also been 
analyzed and reported in a previous study conducted by our 
group.5 These data have been included for analysis in this 
study to provide a clearer perspective of the trends in GBS 
infections. This study was approved by the Ethics Commit-
tee of Guangzhou Women and Children’s Medical Center.
antimicrobial susceptibility testing
Identification of GBS is based on the following tests: Gram 
stain, catalase, automated bacterial identification system 
CAMP, hippurate hydrolysis, and a commercial automatic 
bacterial identification system (VITEK 2 COMPACT, bio-
Mérieux, Marcy L’Étoile, France). An MDR isolate refers 
to an isolate, which is non-susceptible to aminoglycosides, 
macrolides/lincosamides, and/or tetracyclines.6,18,22 The 
test results of GBS isolates were collected from electronic 
databases of the hospital information management system. 
Antibacterial susceptibility testing of all 11 isolates in which 
resistance genes were detected was performed by disk dif-
fusion, according to the Clinical and Laboratory Standards 
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Institute methods and interpretation criteria for Streptococcus 
spp. β-Hemolytic Group.25
Molecular analysis by PcR-based assays
Detection of tetO, ant6, lnuB, and ant9 genes was achieved 
by PCR. The PCR was conducted in a final volume of 50 µL 
of 0.8× PCR buffer (50 mM KCl, 10 mM Tris-HCl [pH 9.0], 
0.1% Triton X-100, 0.01% [wt/vol] stabilizer, 1.5 mM MgCl
2
) 
containing 300 µM deoxynucleoside triphosphates, 3.5 mM 
MgCl
2
, 2 U Taq polymerase (Takara, Kusatsu, Japan), and 10 
ng of template DNA, extracted by Lysis Buffer for Microor-
ganism for direct PCR (Takara); primer concentrations were 
all 0.5 µM. The PCR was conducted on a DNA thermal cycler 
(Bio-Rad, Hercules, CA, USA) with the following cycling 
conditions: an initial cycle of 3 minutes at 94°C (5 minutes 
for tetO); 30 cycles of 30 seconds of denaturation at 94°C, 30 
seconds of annealing at 55°C, and 50 seconds of extension at 
72°C (45 seconds for tetO); followed by 33 cycles of elonga-
tion at 72°C. The PCR products were analyzed by electro-
phoresis on a 2% agarose gel at 220 V for 45 minutes in 0.5× 
Tris-borate-EDTA buffer.26,27 Visualization and image acqui-
sition were performed with gold view (SBS, Beijing, China) 
and ultra-violet transillumination. The results are shown in 
the accompanying figures. Primers used for the detection of 
genes were as follows: tetO_F: 5′-AACTTAGGCATTCTG-
GCTCAC-3′ and tetO_R: 5′-TCCCACTGTTCCATATC-
GTCA-3′; ant6_F: 5′-CCAATGATGCTGATTGTATCG-3′ 
and ant6_R: 5′-CTCTTCTATATCAGCGGCATA-3′; 
lnuB_F: 5′-CATGAAAGGGTGAAGAAATG-3′ and 
lnuB_R: 5′-ACCCAATACTGTGAATAACG-3′; ant9_F: 
5′-GGGTTGGCTACTATTGGGATT-3′ and ant9_R: 
5′-AACGTGGCTCTAGTTGATGG-3′. The PCR products 
were extracted and sequenced by BGI (Guangdong, China).
statistical analysis
Statistical analysis was performed using the IBM SPSS 17.0 
software. The chi-squared test was used for  comparisons 
between two groups. Data from the drug susceptibility 
tests were analyzed by the WHONET 5.6 software, and 
graphs were created by the GraphPad Prism 5.0 software. A 
P-value≤0.05 was considered significant.
Results
clinical data of specimens
To evaluate the trends in GBS infection in southern China, 
we integrated previously reported data5 with newly acquired 
data from the present study. From January 2001 to December 
2017, 149 cases of neonatal invasive GBS infections were 
reported at Guangzhou Women and Children’s Medical Cen-
ter. Among those cases, 119 (79.9%) were caused by MDR 
isolates, including 95 (79.8%) that were diagnosed as sepsis, 
and 24 (20.2%) as meningitis (Table 1). Of the 30 infections 
caused by non-MDR isolates, 25 (83.3%) had diagnoses of 
sepsis and 5 (16.7%) had diagnoses of meningitis. No sig-
nificant differences were noted in the proportions of sepsis 
and meningitis cases between MDR and non-MDR isolates. 
Among the 119 MDR isolates, 34 (28.6%) were from EOD 
cases. The number of EOD and LOD cases caused by non-
MDR isolates were 11 (36.7%) and 19 (63.3%), respectively. 
The proportions of MDR and non-MDR cases between EOD 
and LOD cases were not significantly different. The MDR 
and non-MDR isolates showed no differences in clinical 
characteristics of the neonatal disease by age (Table 1). How-
ever, most of the isolates from female cases were reported 
as MDR infections, whereas those from male cases were 
predominantly caused by non-MDR isolates (P=0.019).
Trends in the epidemiology of neonatal 
invasive gBs infection from 2011 to 2017
The overall proportion of MDR isolates among all GBS 
isolates under study from 2011 to 2017 was 79.9%. Between 
2011 and 2013, the number of MDR cases rose from 7 to 
11. From 2014 onward, the annual number of MDR cases 
was maintained at >20. The annual percentages of MDR 
Table 1 clinical characteristics of gBs isolates in neonatal invasive infections from 2011 to 2017
 Specimens All cases
(n=149)
MDR
(n=119)
Non-MDR
(n=30)
P-value
cases age (days) Mean ± sD 20±19.3 20±19.6 17±18.1 0.543
Median 15 16 12 –
sex ratio (male/female) 0.80 0.65 1.72 0.019
symptom sepsis only 120 (80.5) 95 (79.8) 25 (83.3) 0.665
Meningitis 29 (19.5) 24 (20.2) 5 (16.7)
Diseases eOD (0–6 days) 45 (30.2) 34 (28.6) 11 (36.7) 0.388
lOD (7–89 days) 104 (69.8) 85 (71.4) 19 (63.3)
Abbreviations: eOD, early-onset disease; gBs, group B streptococcus; lOD, late-onset disease; MDR, multidrug-resistant.
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isolates from 2011 to 2013 were 70.0%, 78.6%, and 73.3%, 
respectively, which were all less than the overall mean value. 
In contrast to the period 2011–2013, an increasing trend in 
the percentages of MDR isolates was observed from 2014 to 
2017, which were all higher than the overall average. Overall, 
there was an increasing trend in the epidemiology of neonatal 
invasive GBS infections from 2011 to 2017 (Table 2).
MDR isolates partially or fully carried by 
the RR2 gene cluster
A previous study identified an RR2 gene cluster that bears 
multiple antibiotic resistant genes from five MDR strains 
isolated in southern China.23 Thus, it is logical to hypothesize 
that the rise in the number of MDR isolates may be due to the 
spread of the RR2 gene cluster among the GBS population. To 
Figure 1 Representative PcR results of tetO (A), ant6 (B), lnuB (C), and ant9 (D) genes.
Notes: M: Dna ladder. (A) tetO, lane 1: strains 1–1; lane 3: strains 1–2; lane 5: strains 1–3; lanes 2 and 4: no specimen. (B) ant6, lane 1: strains 2–3; lane 2: strains 2–4; lane 
3: strains 2–5; lane 4: strains 2–6; lane 5: strains 2–7; lane 6: strains 2–8; lane 7: no specimen. (C) lnuB, lane 1: strains 2–1; lane 2: strains 2–2; lane 3: strains 2–3; (D) ant9, 
lane 1: strains 1–3; lane 2: strains 2–6; lane 3: strains 2–7.
M M
A B
DC
1,000 bp
750 bp
965 bp
2,000 bp
849 bp
1,000 bp
1,000 bp
750 bp
500 bp
2,000 bp
1,000 bp
750 bp
1,194 bp
500 bp
1 2 3
M 1 2 3
M1 2 3
4 5 1 2 3 4 5 6 7
515 bp
Table 2 MDR isolates in neonatal invasive infection from 2011 
to 2017
Years MDR isolates (n) All isolates (n) Percentage (%)
2011 7 10 70.0
2012 11 14 78.6
2013 11 15 73.3
2014 23 28 82.1
2015 24 30 80.0
2016 22 26 84.6
2017 21 26 80.8
Total 119 149 79.9
Abbreviations: MDR, multidrug-resistant.
verify this hypothesis, eleven isolates (three EOD isolates and 
eight LOD isolates, according to the ratio of MDR cases from 
EOD and LOD) were selected for PCR analysis. This analy-
sis was designed to detect the presence of tetO, lnuB, and 
ant6 genes located upstream, midstream, and downstream, 
respectively, of the RR2 cluster, and which confer resistance 
to tetracycline, clindamycin, and streptomycin, respectively. 
The PCR products of tetO, ant6, and lnuB were detected as 
515, 965, and 849 bp, respectively (Figure 1A–C). Basic 
Local Alignment Search Tool (BLAST) analysis revealed 
that tetO, ant6, and lnuB sequences showed 97%, 99%, and 
99% nucleotide identity, respectively. The sequencing results 
are shown in Figures S1–S4. The genotypic and phenotypic 
details of the selected three EOD cases and eight LOD cases 
are listed in Table 3.
The PCR results showed that all three EOD cases carried 
tetO and ant6, but not lnuB, whereas six of the eight LOD 
cases carried tetO, ant6, and lnuB. One of the LOD cases had 
no ant6, and the other had no lnuB sequences.
The absence of lnuB and ant9
Therefore, it can be concluded that the lnuB gene played 
an important role in EOD and LOD. To further analyze the 
deletion of lnuB genes and determine the presence of the 
ant9 gene near to the lnuB gene, we selected three strains, the 
numbers of which were 1–3, 2–6, and 2–7, with genotypes 
tetO (+)/ant6 (+)/lnuB (–); tetO (+)/ant6 (+)/lnuB (+); and 
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tetO (+)/ant6 (–)/lnuB (+), respectively. The PCR product 
of ant9 was 1,194 bp in length (Figure 1D), and BLAST 
analysis revealed that the ant9 sequences showed 100% 
nucleotide identity. The sequencing results are shown in the 
supplementary figures. As shown in Table 4, lnuB and ant9 
consistently appeared together. This suggests that the relative 
positions of these two genes on RR2 are either close to each 
other or located in the same transmissible element.
Discussion
As GBS has now become an issue of global public health 
concern, a number of cases of MDR GBS have been reported 
worldwide within recent years, especially in Asia.18 The epi-
demiological data of GBS in southern China have historically 
been limited. A previous study suggested that antimicrobial 
resistance of GBS in this area is worsening and more atten-
tion is needed.16 To oversee the trend of MDR GBS infections 
in this area, we combined the data from 2011 to 2014 with 
epidemiological data from 2015 to 2017. Thus, the present 
study provides a broad view of neonatal invasive GBS infec-
tions in southern China, and included 149 cases during the 
7-year study period. The isolation rate of MDR strains from 
neonatal invasive GBS infections between January 2011 and 
December 2017 was 79.9% (119/149), with a significant 
increasing trend in resistance from 2014 to 2017.
The increasing rate at which MDR GBS has been isolated 
from neonates has been critical over the past few years. The 
latest report showed that all strains were sensitive to vanco-
mycin, but not to penicillin, ceftriaxone, or cefotaxime, with 
susceptibility of 1.1%, 1%, and 1%, respectively, among 181 
cases of bloodstream infection.28 In Japan, PRGBS has also 
been reported within the past 5 years.29–31 In Iran, 93.5% 
(n=58) of erythromycin-resistant GBS showed an increased 
Table 3 genotype and phenotype characteristics of the eleven gBs isolates from neonatal invasive infections
Strain
 
Stage
 
Resistance gene Resistance pattern
tetO ant6 lnuB Tetracycline Streptomycin Clindamycin
1–1 eOD + + – + + +
1–2 eOD + + – + + +
1–3 eOD + + – + + +
2–1 lOD + + + + + +
2–2 lOD + + + + + +
2–3 lOD + + + + + +
2–4 lOD + + – + + +
2–5 lOD + + + + + +
2–6 lOD + + + + + +
2–7 lOD + – + + + +
2–8 lOD + + + + + +
Abbreviations: eOD, early-onset disease; gBs, group B streptococcus; lOD, late-onset disease.
Table 4 Presence of resistance genes in three selected strains
Strains tetO ant6 lnuB ant9
1–3 + + – –
2–6 + + + +
2–7 + – + +
minimum inhibitory concentration in response to penicillin.32 
Surveillance in Taiwan showed that levofloxacin-resistant 
GBS isolates increased from 2.2% during 2002–2006 to 
6.2% during 2008–2012.33 Furthermore, a new class of 
resistant GBS has been reported, of which MDR GBS with 
PI-1 (CC17/PI-2b) lost has shown resistance to macrolides, 
lincosamides, tetracycline, high-level streptomycin, and 
kanamycin.34 Chloramphenicol-resistant MDR GBS has also 
been reported, despite the rare occurrence of chloramphenicol 
resistance in GBS.22 The MDR GBS strains that are resistant 
to penicillin form relatively small, less hemolytic colonies.35 
This may be a strategy of GBS to enhance its survival and 
spread in hospital settings, resulting in nosocomial infections, 
and leading to global spread and increased prevalence.36 
These studies have demonstrated the emerging threat of MDR 
GBS isolates to global public health. It is, therefore, essential 
to examine the epidemiology of MDR GBS and characterize 
MDR mechanisms.
In this study, eleven isolates were selected to detect the 
tetO, lnuB, and ant6 genes located upstream, midstream, and 
downstream, respectively, of the RR2 gene cluster, which 
has been previously identified.23 Of these eleven isolates, six 
were from LOD cases and they all carried the tetO, ant6, and 
lnuB genes. None of the three EOD cases carried lnuB genes. 
Therefore, we speculated that MDR GBS isolates of EOD 
mainly carried fragments of the RR2 cluster rather than the 
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complete set. Moreover, a considerable proportion of the LOD 
isolates most likely carried the full range of the RR2 cluster.
Furthermore, three strains (1–3 for EOD, and 2–6 and 
2–7 for LOD) were selected to detect the ant9 gene close to 
the lnuB gene. The lnuB gene was observed to co-occur with 
the ant9 gene in strains causing LOD. In addition, sequences 
of the lnuB and ant9 genes were highly consistent with the 
partial sequence of ICE SGB76 (GenBank accession number 
KF772204) reported by Montilla (Figure 2).37 This suggests 
that the partial RR2 in strain 1–3 might have been deleted 
(Figure 3). Further whole-genome sequencing will be required 
to clarify gene structure and composition of RR2. The BLAST 
analysis revealed that this sequence (aadE, ant9, and lnuB) 
exhibited similarity to the lnu(B)-containing structures previ-
ously identified in Staphylococcus aureus (JQ861959 and 
JX560992).37 Thus, whether the lnuB and ant9 genes in RR2 
are acquired from S. aureus and whether this acquisition leads 
to the emergence of MDR isolates require further investigation.
Conclusion
Here, we reported on the epidemiological characteristics of 
neonatal invasive MDR GBS infections in southern China 
over a 7-year study period. We showed that the proportion of 
MDR isolates has been increasing over time and speculated 
that LOD isolates most likely carry the MDR gene cluster. 
This study provides perspective for further research on the 
stability of the MDR gene cluster and its role in LOD.
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Figure S1 ant6 sequencing map.
180 190 200 210 220 230 240 250 260 270 280
Figure S2 ant9 sequencing map.
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Figure S3 tetO sequencing map.
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Figure S4 lnuB sequencing map.
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